[Organ-preserving treatment in oncogynecology].
The paper discussed the results of organ-saving treatment carried out in 388 cases of cancer of the cervix uteri (Ca in situ), early endometrial carcinoma and stage IIa tumors of the ovary. The choice of the procedure should be made on reliable evidence on tumor extension and morphology. Favorable end results and preservation of reproductive function justify the use of said treatment and opens up new vistas in research.